Skip to main content
Han Tun, MD, Oncology, Jacksonville, FL

Han Win Tun MD


Professor of Medicine at Mayo Clinic in Florida

Join to View Full Profile
  • 4500 San Pablo Rd SJacksonville, FL 32224

  • Phone+1 904-953-2000

Dr. Tun is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1998 - 2001
  • MedStar Health Georgetown University/Harbor Hospital
    MedStar Health Georgetown University/Harbor HospitalResidency, Internal Medicine, 1995 - 1998
  • University Institute of Medicine 1
    University Institute of Medicine 1Class of 1990

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1998 - 2026
  • MD State Medical License
    MD State Medical License 1997 - 1999
  • Hematology
    American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Phase I Study of Pomalidomide and Dexamethasone for relapsed/refractory Primary CNS or Vitreo-Retinal Lymphoma  
    Lisa M DeAngelis, Han W Tun, David Schiff, Kurt A Jaeckle, Christian Grommes, Patrick B Johnston, Craig B Reeder, Thomas E Witzig, Blood

Abstracts/Posters

  • Long-Term Outcome of Patients with Marginal Zone Non-Hodgkin Lymphoma (MZL) Treated with Yttrium-90 Ibritumomab Tiuxetan: The Mayo Clinic Experience
    Han W. Tun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A Phase Ia/Ib Study Exploring the Synthetic Lethality of the Orally Administered Novel BTK Inhibitor, Dtrmwxhs-12 (DTRM-12), in Combination with Everolimus and Pomalid...
    Han W. Tun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • The DIAL Study (Dual Immunomodulation in Aggressive Lymphoma): A Randomized Phase 2 Study of CDX-1127 (Varlilumab) in Combination with Nivolumab in Patients with Relap...
    Han W. Tun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Press Mentions

  • Treasure Trove of Genes Key to Kidney Cancer Revealed by Research
    Treasure Trove of Genes Key to Kidney Cancer Revealed by ResearchJuly 1st, 2014

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: